Vanderbilt Researchers’ Potential Alzheimer’s Therapy Being Tested in Phase 1 Study

VCNDD partners with VUMC and Bayer to develop new therapies for Kidney disease

VCNDD drug candidate enters clinical trials at Vanderbilt.